Drug Approval | March 10, 2023
Zydus receives final approval from the USFDA for Erythromycin Tablets
Erythromycin Tablets USP, 250 mg and 500 mg are used to prevent and treat infections in many different parts of the body
Erythromycin Tablets USP, 250 mg and 500 mg are used to prevent and treat infections in many different parts of the body
The Development Center with its state-of-the art laboratories and flexible pilot capacities is set to become Siegfried's global research and development hub for its Drug Products sites, strengthening the global network
Resomer used in commercial 3D-printed implants for both soft and hard tissue applications
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
The approved product is indicated for the treatment of adult patients with Multiple myeloma, in combination with Dexamethasone
The new powder flow tester can characterize powder flow properties, offering valuable insight for pharmaceutical processing and formulation
lAIH strives to introduce appropriate interventions for nurturing an AMR innovation ecosystem in the country through cohesive efforts across the innovation pyramid
Smart-performance, fully biodegradable biopolymer sourced from renewable raw materials
The audit was commenced for newly renovated manufacturing Block 1, Block 2, and Block 3
Vigabatrin for Oral Solution USP, 500 mg had annual sales of US $233.7 mn in US
Subscribe To Our Newsletter & Stay Updated
